Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Saba Capital Management, L.P. VTN Invesco Trust for Investment Grade New York Municipals 13D/A 14.07% 2y
PW Partners Atlas Fund IV LP BJRI BJs RESTAURANTS INC 13D 5.2% 2y
Advent International, L.P. CCC CCC Intelligent Solutions Holdings Inc. 13D/A 36.8% 2y
RA CAPITAL MANAGEMENT, L.P. JANX Janux Therapeutics, Inc. 13D/A 19.99% 2y
Angeliki Frangou NMM Navios Maritime Partners L.P. 13D/A 16.7% 2y
Fund 1 Investments, LLC BJRI BJs RESTAURANTS INC 13D/A 9.96% 2y
William Bennett Nance, Jr. HGAS Global Gas Corp 13D/A 26.9% 2y
Abel Avellan ASTS AST SpaceMobile, Inc. 13D/A 36.2% 2y
Series R of UM Partners LLC UTZ Utz Brands, Inc. 13D/A 36.1% 2y
2014 Scesaplana I Trust ASTS AST SpaceMobile, Inc. 13D/A 7.6% 2y
William J. Quinn PR Permian Resources Corp 13D/A 11.6% 2y
RA CAPITAL MANAGEMENT, L.P. ETNB 89bio, Inc. Common Stock 13D/A 14.8% 2y
Silver Lake Group, L.L.C. DELL Dell Technologies Inc. 13D/A 23.2% 2y
Michael B. Chancellor LIPO Lipella Pharmaceuticals Inc. 13D/A 18.9% 2y
Lind Global Fund II LP OGEN Oragenics Inc 13G 5.9% 2y
River Road Asset Management, LLC TBRG TruBridge, Inc. 13G/A 4.3% 2y
ROYCE & ASSOCIATES LP GCMG GCM Grosvenor Inc. 13G/A 10.79% 2y
FEDERATED HERMES, INC. AMPH Amphastar Pharmaceuticals, Inc. 13G/A 4.52% 2y
FEDERATED HERMES, INC. MRUS Merus N.V. Common Shares 13G/A 3.98% 2y
AWM Investment Company, Inc. GENK GEN Restaurant Group, Inc. 13G/A 0% 2y
River Road Asset Management, LLC SP SP Plus Corporation 13G/A 2.9% 2y
BAILLIE GIFFORD & CO CPNG Coupang, Inc. 13G/A 10.3% 2y
JENNISON ASSOCIATES LLC ARQT Arcutis Biotherapeutics, Inc. 13G/A 10.8% 2y
Wolf Hill Capital Management, LP DBRHP DigitalBridge Group, Inc. 13G/A 4.9% 2y
Vector Capital Management, L.P. LPSN Liveperson Inc 13D 12.37% 2y
Mitchell P. Kopin ACON Aclarion, Inc. 13G 4.99% 2y
EVGI Limited CCTSF Cactus Acquisition Corp. 1 Ltd 13D 49.85% 2y
Dale Broadrick BRTX BioRestorative Therapies, Inc. 13D/A 14.1% 2y
CHARLES SCHWAB INVESTMENT MANAGEMENT INC TUP Tupperware Brands Corporation 13G/A 10.01% 2y
Axim Planning & Wealth EH EHang Holdings Ltd 13G 6.14% 2y
PERCEPTIVE ADVISORS LLC RLMD Relmada Therapeutics, Inc. 13G/A 0% 2y
Satter Muneer A RNTX Rein Therapeutics, Inc. 13D/A 5.9% 2y
SIT INVESTMENT ASSOCIATES INC JMM Nuveen Multi-Market Income Fund 13G/A 56.63% 2y
SIT INVESTMENT ASSOCIATES INC DHY Ubs Asset Management High Yield Credit Fund 13G/A 4.82% 2y
SCLX Stock Acquisition JV LLC SCLX Scilex Holding Co 13D/A 36.4% 2y
FJ Capital Management LLC HTBK HERITAGE COMMERCE CORP 13G 5.24% 2y
SIT INVESTMENT ASSOCIATES INC FMY First Trust Mortgage Income Fund 13D/A 53.99% 2y
George Economou SHIP Seanergy Maritime Holdings Corp. 13D/A 9.5% 2y
Blackstone Inc. BMBL Bumble Inc. 13D/A 35.8% 2y
SPRUCE HOUSE INVESTMENT MANAGEMENT LLC CMPR CIMPRESS plc 13D/A 7.88% 2y
David A. Lorber PFX PhenixFIN Corp 13D/A 10.1% 2y
Bellevue Capital Partners, LLC NYC American Strategic Investment Co. 13D/A 48.1% 2y
GOLDMAN SACHS GROUP INC QBTS D-Wave Quantum Inc. 13G/A 1.9% 2y
Shoshana Shendelman APLT Applied Therapeutics, Inc. Common Stock 13D/A 8.2% 2y
Madison Square Garden Entertainment Corp. TSQ Townsquare Media, Inc. 13D/A 11.5% 2y
Carlyle Group Management L.L.C. CG Carlyle Group Inc. 13D/A 39% 2y
Cano Health, Inc. MSPR MSP Recovery, Inc. 13D/A 20.1% 2y
Redmile Group, LLC ABSI Absci Corp 13D/A 7.4% 2y
Saba Capital Management, L.P. SABA Saba Capital Income & Opportunities Fund II 13D/A 14.29% 2y
CHAI TRUST CO LLC PARR Par Pacific Holdings, Inc. 13D/A 3.7% 2y